近视前期的危险因素识别及干预策略研究进展
Risk Factors Identification and Intervention Strategies for Premyopia
DOI: 10.12677/acm.2026.162659, PDF,   
作者: 蒋妍凯, 杨智宽*:暨南大学附属爱尔眼科医院,广东 广州;湖南爱尔眼视光研究所,湖南 长沙;爱尔眼科医院集团股份有限公司,湖南 长沙;李剑华:暨南大学附属爱尔眼科医院,广东 广州;爱尔眼科医院集团股份有限公司,湖南 长沙
关键词: 近视前期危险因素干预措施Premyopia Risk Factors Intervention Strategies
摘要: 近视前期作为近视防控的关键窗口期,以远视储备快速消耗、眼轴增长加速为核心特征,其防控对于降低近视发生风险具有重要临床意义。近年来,随着儿童青少年近视患病率持续上升,近视前期的流行病学特征、危险因素及干预措施受到广泛关注。现有研究表明,遗传因素、近距离用眼负荷增加、户外活动不足及屈光储备下降等与近视前期发生密切相关。行为与环境干预、光学及药物干预均被证实可在一定程度上延缓近视发生,其中周边离焦光学设计、低浓度阿托品及新型光学疗法在近视前期人群中的应用显示出较为稳定的防控效果。近年来,多模式联合干预及个体化干预策略逐渐成为研究热点,但其长期疗效、安全性及适用人群仍有待高质量研究进一步明确。本文系统综述近视前期的流行病学特征、主要危险因素及最新干预研究进展,为儿童青少年近视的早期防控提供循证依据。
Abstract: Premyopia represents a critical transitional stage preceding the onset of myopia and is characterized by accelerated axial elongation and progressive depletion of hyperopic reserve. Early identification and intervention during this period may reduce the risk of myopia development. With the rising prevalence of myopia among children and adolescents, increasing attention has been directed toward the epidemiology, associated risk factors, and preventive interventions for premyopia. Current evidence suggests that genetic susceptibility, increased near-work exposure, insufficient outdoor activity, and reduced hyperopic reserve are key factors associated with the development of premyopia. A range of interventions, including behavioral and environmental modifications, optical approaches, and pharmacologic treatments, have demonstrated varying degrees of efficacy in delaying myopia onset. In particular, peripheral defocus-based optical designs, low-dose atropine, and emerging optical therapies have shown consistent preventive effects in premyopic populations. Recently, multimodal and individualized intervention strategies have been proposed; however, robust evidence regarding their long-term efficacy, safety, and optimal target populations remains limited. This review summarizes current evidence on the epidemiology, major risk factors, and recent advances in intervention strategies for premyopia, providing an evidence-based framework for early myopia prevention in children and adolescents.
文章引用:蒋妍凯, 李剑华, 杨智宽. 近视前期的危险因素识别及干预策略研究进展[J]. 临床医学进展, 2026, 16(2): 2522-2530. https://doi.org/10.12677/acm.2026.162659

参考文献

[1] Bullimore, M.A., Ritchey, E.R., Shah, S., Leveziel, N., Bourne, R.R.A. and Flitcroft, D.I. (2021) The Risks and Benefits of Myopia Control. Ophthalmology, 128, 1561-1579. [Google Scholar] [CrossRef] [PubMed]
[2] Pan, W., Saw, S., Wong, T.Y., Morgan, I., Yang, Z. and Lan, W. (2025) Prevalence and Temporal Trends in Myopia and High Myopia Children in China: A Systematic Review and Meta-Analysis with Projections from 2020 to 2050. The Lancet Regional HealthWestern Pacific, 55, Article ID: 101484. [Google Scholar] [CrossRef] [PubMed]
[3] Lawrenson, J.G., Shah, R., Huntjens, B., Downie, L.E., Virgili, G., Dhakal, R., et al. (2023) Interventions for Myopia Control in Children: A Living Systematic Review and Network Meta-Analysis. Cochrane Database of Systematic Reviews, 2023, CD014758. [Google Scholar] [CrossRef] [PubMed]
[4] Harrington, S., Moore, M., Loughman, J., Flitcroft, I. and O’Dwyer, V. (2025) Optimising Non‐Cycloplegic Screening Strategies for Early Detection of Pre‐Myopia and Myopia in Young Children. Ophthalmic and Physiological Optics, 45, 1080-1089. [Google Scholar] [CrossRef] [PubMed]
[5] Wolffsohn, J.S., Flitcroft, D.I., Gifford, K.L., Jong, M., Jones, L., Klaver, C.C.W., et al. (2019) IMI-Myopia Control Reports Overview and Introduction. Investigative Opthalmology & Visual Science, 60, M1-M19. [Google Scholar] [CrossRef] [PubMed]
[6] 中国民族医药协会眼视光学分会, 北京眼视光学会. 中国近视前期管理专家共识(2025年) [J]. 中华眼科杂志, 2025, 61(12): 957-967.
[7] Wu, P., Chuang, M., Choi, J., Chen, H., Wu, G., Ohno-Matsui, K., et al. (2018) Update in Myopia and Treatment Strategy of Atropine Use in Myopia Control. Eye, 33, 3-13. [Google Scholar] [CrossRef] [PubMed]
[8] Morgan, I.G., French, A.N., Ashby, R.S., Guo, X., Ding, X., He, M., et al. (2018) The Epidemics of Myopia: Aetiology and Prevention. Progress in Retinal and Eye Research, 62, 134-149. [Google Scholar] [CrossRef] [PubMed]
[9] McCullough, S., Adamson, G., Breslin, K.M.M., McClelland, J.F., Doyle, L. and Saunders, K.J. (2020) Axial Growth and Refractive Change in White European Children and Young Adults: Predictive Factors for Myopia. Scientific Reports, 10, Article No. 15189. [Google Scholar] [CrossRef] [PubMed]
[10] Moreira-Rosário, A., Lanca, C. and Grzybowski, A. (2025) Prevalence of Myopia in Europe: A Systematic Review and Meta-Analysis of Data from 14 Countries. The Lancet Regional Health-Europe, 54, Article ID: 101319. [Google Scholar] [CrossRef] [PubMed]
[11] Luo, H., Gao, R., Li, T., et al. (2025) Current Status of Hyperopic Reserve among Children and Adolescents—10 PLADs, China, 2020-2024. China CDC Weekly, 7, 1272-1276. [Google Scholar] [CrossRef
[12] Xu, S., Ruan, Z., Wang, Y., Jiang, J., Zhao, F., Tang, X., et al. (2025) Establishment of Myopia Occurrence Prediction Model in Children without Myopia Using Cycloplegic Refraction and Prior Axial Length Change. Ophthalmology, 132, 1260-1272. [Google Scholar] [CrossRef] [PubMed]
[13] Martínez-Albert, N., Bueno-Gimeno, I. and Gené-Sampedro, A. (2023) Risk Factors for Myopia: A Review. Journal of Clinical Medicine, 12, Article No. 6062. [Google Scholar] [CrossRef] [PubMed]
[14] Harb, E.N. and Wildsoet, C.F. (2019) Origins of Refractive Errors: Environmental and Genetic Factors. Annual Review of Vision Science, 5, 47-72. [Google Scholar] [CrossRef] [PubMed]
[15] Wang, J., Qi, Z., Feng, Y., Chen, J., Du, L., Yang, J., et al. (2023) Normative Value of Hyperopia Reserve and Myopic Shift in Chinese Children and Adolescents Aged 3-16 Years. British Journal of Ophthalmology, 108, 1024-1029. [Google Scholar] [CrossRef] [PubMed]
[16] Liu, W., Liu, W. and Wang, C. (2022) Ocular Biometric Parameters of Mild Hyperopia to Mild Myopia Children Aged 6-14 Years from Wenzhou Optometry Center: A Cross-Sectional Study. Frontiers in Medicine, 9, Article ID: 992587. [Google Scholar] [CrossRef] [PubMed]
[17] 中华预防医学会公共卫生眼科分会. 中国学龄儿童眼球远视储备、眼轴长度、角膜曲率参考区间及相关遗传因素专家共识(2022年) [J]. 中华眼科杂志, 2022, 58(2): 96-102.
[18] Cai, W., Hu, Y., Chen, X., Morgan, I.G., He, M. and Ding, X. (2025) Acceleration of Myopic Shifts in Refraction and Axial Elongation Begins in the Premyopia Stage. Investigative Ophthalmology & Visual Science, 66, Article No. 33. [Google Scholar] [CrossRef
[19] Morgan, I.G., Wu, P.C., Ostrin, L.A., Tideman, J.W.L., Yam, J.C., Lan, W., et al. (2021) IMI Risk Factors for Myopia. Investigative Opthalmology & Visual Science, 62, Article No. 3. [Google Scholar] [CrossRef] [PubMed]
[20] Zhang, X., Yang, W., Yang, J., Du, W., Xiang, Y., Wang, X., et al. (2021) Relationship between Family and Myopia: Based on the Jiangsu School Student Myopia Study. Journal of Ophthalmology, 2021, Article ID: 6754013. [Google Scholar] [CrossRef] [PubMed]
[21] Wu, P.C., Chen, C.T., Chang, L., Niu, Y., Chen, M., Liao, L., et al. (2020) Increased Time Outdoors Is Followed by Reversal of the Long-Term Trend to Reduced Visual Acuity in Taiwan Region Primary School Students. Ophthalmology, 127, 1462-1469. [Google Scholar] [CrossRef] [PubMed]
[22] Chen, J., Wang, J., Qi, Z., Liu, S., Zhao, L., Zhang, B., et al. (2024) Smartwatch Measures of Outdoor Exposure and Myopia in Children. JAMA Network Open, 7, e2424595. [Google Scholar] [CrossRef] [PubMed]
[23] Kido, A., Miyake, M. and Watanabe, N. (2024) Interventions to Increase Time Spent Outdoors for Preventing Incidence and Progression of Myopia in Children. Cochrane Database of Systematic Reviews, 2024, CD013549. [Google Scholar] [CrossRef] [PubMed]
[24] Wang, W., Zhang, F., Yu, S., Ma, N., Huang, C., Wang, M., et al. (2023) Prevention of Myopia Shift and Myopia Onset Using 0.01% Atropine in Premyopic Children—A Prospective, Randomized, Double-Masked, and Crossover Trial. European Journal of Pediatrics, 182, 2597-2606. [Google Scholar] [CrossRef] [PubMed]
[25] He, M., Wang, H., Du, B., Han, D., Liu, L., Zhang, Z., et al. (2025) 0.01% Atropine for Myopia Prevention in Pre‐myopia (AMPP Study). Ophthalmic and Physiological Optics, 45, 1924-1934. [Google Scholar] [CrossRef
[26] Yam, J.C., Zhang, X.J., Zhang, Y., Yip, B.H.K., Tang, F., Wong, E.S., et al. (2023) Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in Children: The LAMP2 Randomized Clinical Trial. JAMA, 329, 472-481. [Google Scholar] [CrossRef] [PubMed]
[27] Lee, S.H., Tseng, B.Y., Wang, J.H. and Chiu, C.J. (2024) Efficacy and Safety of Low-Dose Atropine on Myopia Prevention in Premyopic Children: Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 13, Article No. 1506. [Google Scholar] [CrossRef] [PubMed]
[28] Zaabaar, E., Zhang, Y., Kam, K.W., Zhang, X.J., Tham, C.C., Chen, L.J., et al. (2024) Low-Concentration Atropine for Controlling Myopia Onset and Progression in East Asia. Asia-Pacific Journal of Ophthalmology, 13, Article ID: 100122. [Google Scholar] [CrossRef] [PubMed]
[29] Tariq, F., Mobeen, R., Wang, X., Lin, X., Bao, Q., Liu, J., et al. (2023) Advances in Myopia Prevention Strategies for School-Aged Children: A Comprehensive Review. Frontiers in Public Health, 11, Article ID: 1226438. [Google Scholar] [CrossRef] [PubMed]
[30] 中国医师协会眼科医师分会眼视光专业委员会中华医学会眼科学分会眼视光学组. 低浓度阿托品滴眼液在儿童青少年近视防控中的应用专家共识(2024) [Z]. 2024.
[31] Li, Y., Yip, M., Ning, Y., Chung, J., Toh, A., Leow, C., et al. (2024) Topical Atropine for Childhood Myopia Control. JAMA Ophthalmology, 142, 15-23. [Google Scholar] [CrossRef] [PubMed]
[32] Lam, C.S.Y., Tang, W.C., Tse, D.Y., Lee, R.P.K., Chun, R.K.M., Hasegawa, K., et al. (2019) Defocus Incorporated Multiple Segments (DIMS) Spectacle Lenses Slow Myopia Progression: A 2-Year Randomised Clinical Trial. British Journal of Ophthalmology, 104, 363-368. [Google Scholar] [CrossRef] [PubMed]
[33] Lam, C.S., et al. (2022) Myopia Control Effect of Defocus Incorporated Multiple Segments (DIMS) Spectacle Lens in Chinese Children: Results of a 3-Year Follow-Up Study. British Journal of Ophthalmology, 106, 1110-1114.
[34] Li, X., Huang, Y., Liu, C., Chang, X., Cui, Z., Yang, Q., et al. (2025) Myopia Control Efficacy of Spectacle Lenses with Highly Aspherical Lenslets: Results of a 5-Year Follow-Up Study. Eye and Vision, 12, Article No. 10. [Google Scholar] [CrossRef] [PubMed]
[35] Sun, A., Li, X., Zhu, P., Xie, F. and Wu, Y. (2025) Real‐World Efficacy of Plano Lenses with Highly Aspherical Lenslets in Children with Pre‐myopia: A Prospective Cohort Study. Ophthalmic and Physiological Optics, 45, 1468-1474. [Google Scholar] [CrossRef] [PubMed]
[36] Rappon, J., Chung, C., Young, G., Hunt, C., Neitz, J., Neitz, M., et al. (2022) Control of Myopia Using Diffusion Optics Spectacle Lenses: 12-Month Results of a Randomised Controlled, Efficacy and Safety Study (CYPRESS). British Journal of Ophthalmology, 107, 1709-1715. [Google Scholar] [CrossRef] [PubMed]
[37] Zhang, H., Lam, C.S.Y., Tang, W., Leung, M., Qi, H., Lee, P.H., et al. (2022) Myopia Control Effect Is Influenced by Baseline Relative Peripheral Refraction in Children Wearing Defocus Incorporated Multiple Segments (DIMS) Spectacle Lenses. Journal of Clinical Medicine, 11, Article No. 2294. [Google Scholar] [CrossRef] [PubMed]
[38] Tang, W.-T., et al. (2023) Orthokeratology with Increased Compression Factor in Adolescent Myopia Control: A 2-Year Prospective Randomized Clinical Trial. International Journal of Ophthalmology, 16, 770-777.
[39] Zhang, X.J., Zaabaar, E., French, A.N., Tang, F.Y., Kam, K.W., Tham, C.C., et al. (2024) Advances in Myopia Control Strategies for Children. British Journal of Ophthalmology, 109, 165-176. [Google Scholar] [CrossRef] [PubMed]
[40] Jiang, Y., Zhu, Z., Tan, X., Kong, X., Zhong, H., Zhang, J., et al. (2022) Effect of Repeated Low-Level Red-Light Therapy for Myopia Control in Children: A Multicenter Randomized Controlled Trial. Ophthalmology, 129, 509-519. [Google Scholar] [CrossRef] [PubMed]
[41] He, X., Wang, J., Zhu, Z., Xiang, K., Zhang, X., Zhang, B., et al. (2023) Effect of Repeated Low-Level Red Light on Myopia Prevention among Children in China with Premyopia: A Randomized Clinical Trial. JAMA Network Open, 6, e239612. [Google Scholar] [CrossRef] [PubMed]
[42] Leber, M.H.M., Milbradt, T.L., Fujimura, A.Y., Silva, Y.P., Amaral, D.C., Leber, H.M., et al. (2025) Effect of Repeated Intense Foveal Red-Light Therapy in Children with Pre-Myopia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Current Eye Research, 50, 1085-1093. [Google Scholar] [CrossRef] [PubMed]
[43] Liu, G., Rong, H., Liu, Y., Wang, B., Du, B., Song, D., et al. (2024) Effectiveness of Repeated Low-Level Red Light in Myopia Prevention and Myopia Control. British Journal of Ophthalmology, 108, 1299-1305. [Google Scholar] [CrossRef] [PubMed]
[44] Deen, N., Zhu, Z., Qi, Z., Aung, Y.Y., Bulloch, G., Miao, D., et al. (2025) Three-Month Interim Analyses of Repeated Low-Level Red-Light Therapy in Myopia Control in Schoolchildren: A Pilot Multi-Ethnic Randomized Controlled Trial. Ophthalmic Epidemiology, 1-9. [Google Scholar] [CrossRef] [PubMed]
[45] Chen, Y., Xiong, R., Yang, S., Zhu, Z., Li, H., Xiang, K., et al. (2024) Safety of Repeated Low-Level Red-Light Therapy for Myopia: A Systematic Review. Asia-Pacific Journal of Ophthalmology, 13, Article ID: 100124. [Google Scholar] [CrossRef] [PubMed]
[46] Liu, H., Yang, Y., Guo, J., Peng, J. and Zhao, P. (2023) Retinal Damage after Repeated Low-Level Red-Light Laser Exposure. JAMA Ophthalmology, 141, 693-695. [Google Scholar] [CrossRef] [PubMed]
[47] Xiong, R., Zhu, Z., Jiang, Y., Kong, X., Zhang, J., Wang, W., et al. (2022) Sustained and Rebound Effect of Repeated Low‐Level Red‐Light Therapy on Myopia Control: A 2‐Year Post‐Trial Follow‐Up Study. Clinical & Experimental Ophthalmology, 50, 1013-1024. [Google Scholar] [CrossRef] [PubMed]
[48] Yuan, Y., Zhu, C., Liu, M., Zhou, Y., Yang, X., Zheng, B., et al. (2021) Efficacy of Combined Orthokeratology and 0.01% Atropine for Myopia Control: The Study Protocol for a Randomized, Controlled, Double-Blind, and Multicenter Trial. Trials, 22, Article No. 863. [Google Scholar] [CrossRef] [PubMed]
[49] Wu, G., Dai, X., Tian, J. and Sun, J. (2024) Efficacy of Repeated Low-Level Red-Light Therapy Combined with Optical Lenses for Myopia Control in Children and Adolescents. American Journal of Translational Research, 16, 4903-4911. [Google Scholar] [CrossRef] [PubMed]
[50] Xiong, R., Wang, W., Tang, X., He, M., Hu, Y., Zhang, J., et al. (2024) Myopia Control Effect of Repeated Low-Level Red-Light Therapy Combined with Orthokeratology: A Multicenter Randomized Controlled Trial. Ophthalmology, 131, 1304-1313. [Google Scholar] [CrossRef] [PubMed]
[51] Eppenberger, L.S., Grzybowski, A., Schmetterer, L. and Ang, M. (2024) Myopia Control: Are We Ready for an Evidence Based Approach? Ophthalmology and Therapy, 13, 1453-1477. [Google Scholar] [CrossRef] [PubMed]
[52] Patterson, S.M., Cadogan, C.A., Kerse, N., Cardwell, C.R., Bradley, M.C., Ryan, C., et al. (2014) Interventions to Improve the Appropriate Use of Polypharmacy for Older People. Cochrane Database of Systematic Reviews, 2014, CD008165. [Google Scholar] [CrossRef] [PubMed]
[53] Izquierdo, M., Merchant, R.A., Morley, J.E., Anker, S.D., Aprahamian, I., Arai, H., et al. (2021) International Exercise Recommendations in Older Adults (ICFSR): Expert Consensus Guidelines. The Journal of Nutrition, Health and Aging, 25, 824-853. [Google Scholar] [CrossRef] [PubMed]
[54] Mohr, D.C., Schueller, S.M., Montague, E., Burns, M.N. and Rashidi, P. (2014) The Behavioral Intervention Technology Model: An Integrated Conceptual and Technological Framework for Ehealth and Mhealth Interventions. Journal of Medical Internet Research, 16, e146. [Google Scholar] [CrossRef] [PubMed]
[55] Alyass, A., Turcotte, M. and Meyre, D. (2015) From Big Data Analysis to Personalized Medicine for All: Challenges and Opportunities. BMC Medical Genomics, 8, Article No. 33. [Google Scholar] [CrossRef] [PubMed]
[56] Zhou, P., Wang, D.-D., Fan, L., Yang, L. and Zhao, M.-W. (2023) Thin Central Corneal Thickness May Be a Risk Factor for Myopia Progression in Children. Journal of Ophthalmology, 2023, Article ID: 3815863. [Google Scholar] [CrossRef] [PubMed]
[57] Yap, T.P. and Mishu, M.P. (2024) Pharmaceutical Prescribing Privileges for Optometrists to Combat Childhood Myopia in Singapore: Public Health Policy Review and Analysis. Children, 11, Article No. 1548. [Google Scholar] [CrossRef] [PubMed]
[58] Abdalla, M.M.I. and Mohanraj, J. (2025) Revolutionizing Diabetic Retinopathy Screening and Management: The Role of Artificial Intelligence and Machine Learning. World Journal of Clinical Cases, 13, Article ID: 101306. [Google Scholar] [CrossRef] [PubMed]